Evogene Future Growth
Future criteria checks 2/6
Evogene is forecast to grow earnings and revenue by 35.1% and 62.2% per annum respectively.
Key information
35.1%
Earnings growth rate
n/a
EPS growth rate
Biotechs earnings growth | 37.1% |
Revenue growth rate | 62.2% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 11 Apr 2024 |
Recent future growth updates
No updates
Recent updates
We're Keeping An Eye On Evogene's (TLV:EVGN) Cash Burn Rate
Mar 05Will Evogene (TLV:EVGN) Spend Its Cash Wisely?
Oct 09Will Evogene (TLV:EVGN) Spend Its Cash Wisely?
Jun 26We're Keeping An Eye On Evogene's (TLV:EVGN) Cash Burn Rate
Mar 13Here's Why We're Watching Evogene's (TLV:EVGN) Cash Burn Situation
Oct 07We're Keeping An Eye On Evogene's (TLV:EVGN) Cash Burn Rate
Jun 16Will Evogene (TLV:EVGN) Spend Its Cash Wisely?
Mar 02Here's Why We're Not Too Worried About Evogene's (TLV:EVGN) Cash Burn Situation
May 28Companies Like Evogene (TLV:EVGN) Are In A Position To Invest In Growth
Jan 21What Can We Make Of Evogene's (TLV:EVGN) CEO Compensation?
Nov 30Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 60 | -5 | N/A | N/A | 1 |
12/31/2025 | 32 | -17 | N/A | N/A | 1 |
12/31/2024 | 17 | -21 | N/A | N/A | 1 |
12/31/2023 | 6 | -24 | -22 | -22 | N/A |
9/30/2023 | 6 | -20 | -19 | -18 | N/A |
6/30/2023 | 2 | -23 | -22 | -21 | N/A |
3/31/2023 | 2 | -25 | -23 | -22 | N/A |
12/31/2022 | 2 | -27 | -25 | -24 | N/A |
9/30/2022 | 1 | -31 | -31 | -30 | N/A |
6/30/2022 | 1 | -32 | -29 | -28 | N/A |
3/31/2022 | 1 | -29 | -29 | -28 | N/A |
12/31/2021 | 1 | -28 | -26 | -25 | N/A |
9/30/2021 | 1 | -29 | -24 | -24 | N/A |
6/30/2021 | 1 | -26 | -23 | -22 | N/A |
3/31/2021 | 1 | -24 | -19 | -19 | N/A |
12/31/2020 | 1 | -23 | -20 | -20 | N/A |
9/30/2020 | 1 | -21 | -18 | -17 | N/A |
6/30/2020 | 1 | -21 | -18 | -17 | N/A |
3/31/2020 | 0 | -21 | -19 | -18 | N/A |
12/31/2019 | 1 | -18 | -19 | -18 | N/A |
9/30/2019 | 1 | -18 | -16 | -16 | N/A |
6/30/2019 | 2 | -18 | -16 | -16 | N/A |
3/31/2019 | 2 | -19 | -16 | -16 | N/A |
12/31/2018 | 2 | -21 | -16 | -15 | N/A |
9/30/2018 | 2 | -21 | -16 | -16 | N/A |
6/30/2018 | 2 | -21 | -16 | -15 | N/A |
3/31/2018 | 3 | -21 | -16 | -16 | N/A |
12/31/2017 | 3 | -21 | -17 | -16 | N/A |
9/30/2017 | 4 | -21 | N/A | -17 | N/A |
6/30/2017 | 5 | -21 | N/A | -16 | N/A |
3/31/2017 | 5 | -21 | N/A | -15 | N/A |
12/31/2016 | 7 | -20 | N/A | -12 | N/A |
9/30/2016 | 8 | -18 | N/A | -12 | N/A |
6/30/2016 | 9 | -17 | N/A | -11 | N/A |
3/31/2016 | 10 | -17 | N/A | -12 | N/A |
12/31/2015 | 11 | -17 | N/A | -12 | N/A |
9/30/2015 | 12 | -17 | N/A | -10 | N/A |
6/30/2015 | 12 | -17 | N/A | -9 | N/A |
3/31/2015 | 13 | -16 | N/A | -8 | N/A |
12/31/2014 | 15 | -15 | N/A | -9 | N/A |
9/30/2014 | 17 | -14 | N/A | -8 | N/A |
6/30/2014 | 18 | -12 | N/A | -7 | N/A |
3/31/2014 | 18 | -11 | N/A | -6 | N/A |
12/31/2013 | 15 | -9 | N/A | -5 | N/A |
9/30/2013 | 18 | -5 | N/A | -5 | N/A |
6/30/2013 | 18 | -4 | N/A | -1 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: EVGN is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: EVGN is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: EVGN is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: EVGN's revenue (62.2% per year) is forecast to grow faster than the IL market (3.6% per year).
High Growth Revenue: EVGN's revenue (62.2% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if EVGN's Return on Equity is forecast to be high in 3 years time